demonstrated that following CCL4-induced liver fibrosis in mice, the number of hepatic cDCs and pDCs significantly increased during the early fibrotic regression phase after drug withdrawal, playing a crucial role in fibrosis reversal. This evidence concerns the gene CCL4 and Hepatic fibrosis.